Two case reports described development of severe OHSS, characterized by abdominal ascites requiring drainage and hemoconcentration, in patients treated with GnRH agonist trigger in a GnRH antagonist protocol. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.